Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

PT-141

Bremelanotide, Vyleesi

Quick Stats
Studies 74
Trials 10
Score 4
2025 pubmed 1 citations

A biodegradable suction patch for sustainable transbuccal peptide delivery.

Krupke. Hanna H; Zoratto. Nicole N; Rabut. Lucie L; Gao. Daniel D; Paunović. Nevena N; Klein Cerrejon. David D; Dehapiot. Benoit B; Leroux. Jean-Christophe JC

Key Findings

  • Biodegradable copolyester patches can be mass‑produced and safely dissolve after removal, reducing waste.
  • In dogs, a 10‑minute buccal application of the patch delivered semaglutide with much higher bioavailability than an oral tablet and achieved ~26% of the exposure of a subcutaneous injection for bremelanotide.
  • Ex vivo tests on pig cheek tissue showed the patch, combined with a chemical permeation enhancer, significantly increased the passage of otherwise poorly permeable molecules.

Practical Outcomes

  • For DIY peptide users, this patch offers a needle‑free way to administer PT‑141 and similar peptides, potentially improving convenience and adherence. A short (≈10 min) application is enough to achieve meaningful blood levels, and the biodegradable material means you won’t be adding plastic waste. While still experimental, the data suggest you could replace subcutaneous injections with a buccal patch for certain peptides, pending further human safety testing.

Summary

Scientists made a new, eco‑friendly suction patch you stick on the inside of your cheek that can deliver peptide drugs without a needle. It works for semaglutide (a weight‑loss/diabetes peptide) and bremelanotide (the active ingredient in PT‑141), giving decent blood levels after just a 10‑minute application, and the patch breaks down after use.

Abstract

Despite considerable advances in the systemic delivery of peptides, their susceptibility to gastrointestinal degradation and high molecular weight, which restricts permeability across biological barriers, remain obstacles to oral administration. As a result, most peptide therapies rely on injections to achieve therapeutic effects. Recent studies on a bioinspired suction patch demonstrated positive effects in vivo with three peptides - desmopressin, semaglutide, and teriparatide - yet materials used for patch fabrication were non-degradable. In this work, a more sustainable patch alternative is introduced by replacing previously used materials with biodegradable polymers, aiming for degradation of the patch after removal to reduce environmental impact. A scalable mold casting process was employed to thermally crosslink synthesized and functionalized copolyesters, yielding the desired devices. Mechanical testing across various materials and shapes identified the best-performing polymer, while its degradation was confirmed in both aqueous medium and simulated waste. An ex vivo model using porcine buccal tissue validated the functionality of biodegradable patches, showing enhanced permeation of a poorly permeable dye when combined with a chemical permeation enhancer. In beagle dogs, the bioavailability of semaglutide (4.11 kDa) was substantially improved compared to the commercially available tablet, with an application time of only 10 min. Additionally, the patch achieved a relative bioavailability of 26% for bremelanotide (1.03 kDa) compared to subcutaneous administration. This work underscores the potential of replacing silicone devices with biodegradable alternatives, providing a more sustainable approach for peptide delivery via the buccal suction patch.

Study Information

Provider

pubmed

Year

2025

Date

2025-06-11T00:00:00.000Z

DOI

10.1016/j.jconrel.2025.113947

Citations

1

References

69